Meghmani Organics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
MOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts less than Nifty Microcap 250 and 2.3 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Meghmani Organics Limited reported standalone revenue from operations of Rs. 2,09,181 Lakhs for FY2026, up 4.4% from Rs. 2,00,387 Lakhs in FY2025. Profit after tax surged 88.6% to Rs. 12,526 Lakhs from Rs. 6,642 Lakhs, driven by improved operational efficiency and higher other income. EBITDA margin expanded significantly from 4.15% to 7.4% year-on-year. However, finance costs increased 37% to Rs. 7,322 Lakhs. On consolidated basis, PAT was much lower at Rs. 2,874 Lakhs due to losses in subsidiaries, particularly in the Pigment segment. The company also announced a proposed amalgamation of wholly-owned subsidiaries Kilburn Chemicals and Meghmani Crop Nutrition, pending NCLT and other approvals. Auditors issued an unmodified (clean) opinion on the financial statements.
Strong standalone profitability growth with margin expansion is positive for shareholders, but the large gap between standalone and consolidated PAT highlights underlying subsidiary losses. The proposed amalgamation could simplify group structure if approved.